Desonide


  • Product Name
  • CasNo
  • MF
  • MW
  • Content
  • Appearance
  • Packing
  • Apply
  • Desonide
  • 638-94-8
  • C<sub>24</sub>H<sub>32</sub>O<sub>6</sub>
  • 416.514
  • Powder
Inquiry

Factory supplie good quality Desonide 638-94-8 with stock

  • Molecular Formula:C24H32O6
  • Molecular Weight:416.514
  • Appearance/Colour:Powder 
  • Vapor Pressure:7.16E-16mmHg at 25°C 
  • Melting Point:274 - 275oC 
  • Refractive Index:1.598 
  • Boiling Point:580.1 °C at 760 mmHg 
  • PKA:12.87±0.10(Predicted) 
  • Flash Point:196.9 °C 
  • PSA:93.06000 
  • Density:1.3 g/cm3 
  • LogP:2.32670 

Desonide(Cas 638-94-8) Usage

Indications

Desonide (DesOwen, Tridesilon) is a synthetic corticosteroid.

Manufacturing Process

Preparation of 11β,21-Dihydroxy-16α,17α-Isopropylidenedioxy-1,4- Pregnadiene-3,20-Dione: A solution of 11β,16α,17α,21-tetrahydroxy-1,4- pregnadiene-3,20-dione (40 mg) in acetone (10 ml) containing hydrochloric acid (three drops; d 1.19) is boiled 3n the steam bath for two minutes and then allowed to stand for eighteen hours at room temperature. The reaction mixture is diluted with water (50 ml) and extracted with chloroform (3x25 ml), the combined extracts then being washed with water (30 ml) and dried over anhydrous sodium sulfate. The residue obtained by removal of solvent crystallized from ethyl acetate-petroleum ether as small plates (25 mg), melting point 257°-260°C.

Therapeutic Function

Antiinflammatory

Definition

ChEBI: Triamcinolone acetonide with hydrogen instead of the fluorine substituent at position 9. A corticosteroid anti-inflammatory, it is used topically as a cream, ointment or lotion for the treatment of various skin disorders.

Brand name

Desowen (Galderma); Tridesilon (Perrigo).

InChI:InChI=1/C24H32O6/c1-21(2)29-19-10-16-15-6-5-13-9-14(26)7-8-22(13,3)20(15)17(27)11-23(16,4)24(19,30-21)18(28)12-25/h7-9,15-17,19-20,25,27H,5-6,10-12H2,1-4H3/t15-,16-,17-,19+,20+,22-,23-,24+/m0/s1

638-94-8 Relevant articles

-

Bernstein et al.

, p. 4573 (1959)

-

Synthetic method for preparing 16,17 ketal

-

Paragraph 0035-0039; 0044-0047, (2020/04/06)

The invention relates to a synthetic met...

A synthesis method of budesonide (by machine translation)

-

Paragraph 0030; 0032; 0038; 0046; 0054, (2018/07/30)

The invention discloses a budesonide syn...

Pregnane derivatives 16, 17 - acetal (ketone) preparation method

-

Paragraph 0037-0039, (2017/08/31)

Disclosed is a method for preparing a pr...

NOVEL PROCESS FOR PREPARATION OF GLUCOCORTICOID STEROIDS

-

, (2016/08/23)

The present invention discloses a proces...

638-94-8 Process route

desonide
13951-70-7

desonide

acetone
67-64-1

acetone

desonide
638-94-8

desonide

Conditions
Conditions Yield
With boron trifluoride; In tetrahydrofuran; acetonitrile; at -5 - 10 ℃; Inert atmosphere;
85%
With methanesulfonic acid; at -10 ℃; for 0.133333h; Temperature;
C<sub>26</sub>H<sub>32</sub>O<sub>7</sub>

C26H32O7

desonide
638-94-8

desonide

Conditions
Conditions Yield
With sodium hydroxide; In methanol; at 30 ℃; for 0.666667h; Temperature; Inert atmosphere; Large scale;
81%

638-94-8 Upstream products

  • 13951-70-7
    13951-70-7

    desonide

  • 25092-25-5
    25092-25-5

    11β,16α,17α,21-tetrahydroxy-1,4-pregnadiene-3,20-dione 16,17-acetonide 21-acetate

  • 37413-91-5
    37413-91-5

    2-((10S,13S,14S)-10,13-dimethyl-3-oxo-6,7,8,10,12,13,14,15-octahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate

  • 77017-20-0
    77017-20-0

    16α,17α,21-trihydroxypregna-1,4,9(11)-triene-3,20-dione-21-acetate

638-94-8 Downstream products

  • 117782-95-3
    117782-95-3

    11β-hydroxy-16α,17α-<(1-methylethylidene)bis(oxy)>-3-oxoandrosta-1,4-diene

  • 51372-29-3
    51372-29-3

    budesonide

  • 161115-59-9
    161115-59-9

    desisobutyryl ciclesonide

  • 3385-03-3
    3385-03-3

    flunisolide

*Product Name:
*Email:
*Description:
*Code:
Contact Now